Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
57.50
-1.96 (-3.30%)
At close: Feb 11, 2026, 4:00 PM EST
57.50
0.00 (0.00%)
After-hours: Feb 11, 2026, 7:00 PM EST

Haemonetics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21
2,6723,1754,3354,1753,2635,694
Market Cap Growth
-25.37%-26.76%3.83%27.92%-42.69%12.14%
Enterprise Value
3,5344,1455,0114,7173,8095,827
Last Close Price
57.5063.1985.3582.7563.85112.04
PE Ratio
15.7518.9336.8736.1775.2471.65
Forward PE
11.1313.2120.4925.4523.8233.88
PS Ratio
2.092.333.313.573.296.54
PB Ratio
2.953.874.515.104.367.78
P/TBV Ratio
---54.93--
P/FCF Ratio
8.6722.2930.1851.0843.0879.34
P/OCF Ratio
7.8917.4723.8515.2918.9552.33
PEG Ratio
1.021.001.392.421.362.46
EV/Sales Ratio
2.683.053.834.043.846.69
EV/EBITDA Ratio
9.6811.6516.9618.7219.8731.60
EV/EBIT Ratio
13.6416.7824.2328.2136.2258.21
EV/FCF Ratio
11.4729.1034.8957.7150.2881.19
Debt / Equity Ratio
1.341.560.911.021.121.08
Debt / EBITDA Ratio
3.363.492.863.284.144.02
Debt / FCF Ratio
3.989.016.0810.1611.0710.98
Net Debt / Equity Ratio
0.951.190.720.670.770.81
Net Debt / EBITDA Ratio
2.362.742.352.163.023.23
Net Debt / FCF Ratio
2.806.854.836.677.648.30
Asset Turnover
0.530.590.630.620.540.56
Inventory Turnover
1.541.712.071.981.501.49
Quick Ratio
1.040.881.291.850.951.26
Current Ratio
1.751.622.563.061.712.74
Return on Equity (ROE)
19.30%18.83%13.22%14.72%5.86%12.05%
Return on Assets (ROA)
6.45%6.65%6.26%5.51%3.57%4.05%
Return on Invested Capital (ROIC)
11.27%11.33%10.62%10.14%5.40%8.96%
Return on Capital Employed (ROCE)
13.30%13.20%10.90%9.90%7.40%6.40%
Earnings Yield
6.57%5.28%2.71%2.76%1.33%1.40%
FCF Yield
11.53%4.49%3.31%1.96%2.32%1.26%
Buyback Yield / Dilution
6.04%1.30%0.04%-0.13%-0.12%1.01%
Updated Feb 5, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q